ArticleJournal of thoracic disease2022
Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution.
Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 16 citations in OpenAlex.
- Redefining treatment interval in lung cancer surgery in the era of prehabilitation: a systematic review.Translational lung cancer research · 2025Review
- Lung Cancer Under Siege in Spain: Timeliness, Treatment, and Survival Before and After the COVID-19 Pandemic.Cancers · 2025Article
- Delays in phases of care from identification to treatment of suspicious lung nodules.JTCVS open · 2025Article
- The Ligurian Experience in the Management of Lung Cancer: Organizational Models and New Perspectives.Healthcare (Basel, Switzerland) · 2024Article
- Persistent Inequality in Access to Rheumatology Care for Females After the COVID-19 Pandemic.Musculoskeletal care · 2024Article
- Unveiling the Effects of the COVID-19 Pandemic on Lung Cancer Surgery.Medicina (Kaunas, Lithuania) · 2024Article
- Resource allocation during the coronavirus disease 2019 pandemic and the impact on patients with lung cancer: a systematic review.Interdisciplinary cardiovascular and thoracic surgery · 2023Article
- Lung Cancer Treatment Trends During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Claims and Order Data Analysis (2019-2021).JTO clinical and research reports · 2023Article
- Changes in Perioperative Outcomes after Robotic-Assisted Pulmonary Lobectomy during the COVID-19 Era.Surgery in practice and science · 2023Article
- Narrowing the therapeutic window?-A case-control study on the influence of the COVID-19 pandemic on the primary UICC stage of NSCLC.Journal of thoracic disease · 2023Article
- Lung cancer surgery during COVID-19: keep calm and operate on.Journal of thoracic disease · 2022Article
- Surgical treatment of lung cancer during the coronavirus disease 2019 (COVID-19) pandemic: lessons learned.Journal of thoracic disease · 2022Article
- Lung cancer surgical treatment during the pandemic: a challenging situation.Journal of thoracic disease · 2022Article
- Impact of COVID-19 Pandemic on Advanced Non-small Cell Lung Cancer Treatment at a Japanese Hospital.Cancer diagnosis & prognosisArticle
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of COVID-19 has been felt in every field of medicine. We sought to understand how lung cancer surgery was affected at a high volume institution. We hypothesized that patients would wait longer for surgery, have more advanced tumors, and experience more complications during the COVID-19 crisis. Methods: A retrospective review was conducted, comparing pathologically confirmed non-small cell lung cancer (NSCLC) surgical cases performed in 2019 to cases performed from March to May 2020, during the height of the COVID-19 crisis. Clinical and pathologic stage, tumor size, time to surgery, follow up time, and complications were evaluated. Results: A total of 375 cases were performed in 2019 Conclusions: Surgical wait time, pathologic tumor size, and complications were not different among patients undergoing surgery before
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.